Study of Viral Load and Maternal-fetal Serology in the Interpretation of the Vertical Transmission of SARS Cov-2 (COVID-19) During Pregnancy

Official Title

Study of Viral Load and Maternal-fetal Serology in the Interpretation of the Vertical Transmission of SARS Cov-2 During Pregnancy

Brief Summary

The study evaluates the distribution of immunological and virological profiles of newborns patients. Mothers of these children have a proven infection to SARS Cov-2 during pregnancy.

Status

Completed

Conditions

SARS-COV2

Interventions

Diagnostic Test: biological samples day of delivery

mother samples: serology, viremia, nasopharyngeal swab, vaginal swab, placenta swab, piece of placenta newborn: serology, viremia, nasopharyngeal aspiration

Eligibility Criteria

Inclusion Criteria:

- pregnant woman

- diagnosed with Sars Cov-2 during pregnancy

- singleton or twin pregnancy

- informed consent

Exclusion Criteria:

- virological or serological samples not done the day of delivery

Eligibility Gender

Female

Eligibility Age

Minimum: 18 Years ~ Maximum: N/A

Countries

France

Locations

Chu Besancon
Besancon, France

NCT Number

NCT04402918

Disclaimer:

Expanded Access program information for companies listed in the Expanded Access Company Directory is pulled daily from ClinicalTrials.gov, a resource provided by the National Institutes of Health in cooperation with the U.S. Food and Drug Administration. Click here for more information about ClinicalTrials.gov.

(202) 849 - 2075

1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036

admin@reaganudall.org

Centre Hospitalier Universitaire de Besancon

Study of Viral Load and Maternal-fetal Serology in the Interpretation of the Vertical Transmission of SARS Cov-2 (COVID-19) During Pregnancy

Disclaimer:

Subscribe for updates from the Reagan-Udall Foundation for the FDA